Document:

<PAGE>
                                                                    Exhibit 10.1

                         SEVERANCE AND RELEASE AGREEMENT

        THIS SEVERANCE AND RELEASE AGREEMENT ("Agreement") is between Elizabeth
Hall ("Employee") and N2H2, INC. ("Employer") and is in consideration of their
mutual undertakings as set forth in this Agreement.

        Because the parties to this Agreement wish to set forth clearly the
terms and conditions of Employee's departure from his/her employment, they agree
as follows:

1.      This Agreement shall not be construed as an admission by Employee of any
        misconduct or impropriety. Additionally, this Agreement shall not be
        construed as an admission by Employer that it acted wrongfully with
        respect to Employee.

2.      Employee's last day of employment will be April 17, 2002.

3.      Employer will pay Employee as follows:

        3.1    Employer will pay Employee for all wages earned through the
               effective date identified in paragraph 2.

        3.2    Employer will pay Employee for all Employee's earned but unused
               vacation on Employee's final paycheck on April 30, 2002.

        3.3    If Employee is generally compensated in all or in part by
               commissions, Employer will pay Employee his/her quarterly
               commissions through March 31, 2002, if any due, consistent with
               the Sales Compensation plan dated November 1, 2001.

        3.4    If Employee has vested stock option rights, the exercise of those
               rights shall be governed by the terms of any applicable Stock
               Option Agreement or granting documents and shall not be affected
               by this Severance and Release Agreement.

        Employee expressly agrees that he/she is not otherwise entitled to any
        other compensation in the way of base salary, bonus, incentive
        compensation, separation pay, stock options or otherwise.

4.      Employer will pay Employee six weeks' severance pay (based on base pay +
        non-recoverable draw) in the amount of Fifteen Thousand Nine Hundred
        Twenty Three Dollars and Eight Cents ($15,923.08), less all lawful or
        required deductions, upon expiration of seven days following the
        execution of this Agreement.

5.      Until April 30, 2002, Employer will continue its contributions towards
        Employee's group medical and dental insurance. After April 30, 2002,
        Employee may elect COBRA medical and dental plan continuation coverage
        for himself/herself and/or his/her covered dependents for the time
        period and under such conditions as are provided by COBRA. If Employee
        elects COBRA effective May 1, 2002, then Employer will pay the COBRA
        premium for Employee and Employee's eligible dependents for up to two
        months. After July 1, 2002, Employee must self-pay to continue his/her
        COBRA coverage and coverage for any dependants.

<PAGE>

6.      If Employee files for unemployment compensation benefits, Employer will
        confirm to the Washington State Employment Security Department that
        Employee and Employer agreed to a mutual resignation and Employer will
        not contest Employee's eligibility for unemployment compensation.

7.      Employee will direct all requests for references to Employer's Human
        Resources Department, which will confirm the dates of Employee's
        employment and his/her job title.

8.      Employer and Employee may acknowledge to persons within and outside the
        company that their parting was on mutually satisfactory terms. The
        parties will use their best efforts, however, to keep the terms of this
        Agreement confidential. Employee may disclose the terms of this
        Agreement to his/her immediate family. Employer may disclose the terms
        of this Agreement to its officers, directors, trustees, or managers who
        have a need to know. Either party may disclose the terms of this
        Agreement to their respective attorneys, accountants, financial
        advisers, auditors, or similar advisors, or in response to legal process
        or government requests. Third persons who are authorized to be informed
        of the terms of this Agreement shall in turn be advised of this
        confidentiality provision and requested to maintain it.

        8.1.   Employee also agrees that though he/she is no longer employed by
               Employer he/she will continue to respect the confidences of
               Employer, its officers, directors, or employees and its clients,
               in accordance with the "N2H2 Mutual Non-Disclosure Agreement and
               Employee Intellectual Property Agreement" which he/she signed on
               November 5, 2001.

9.      Employee shall immediately review all personal items and return to
        Employer all company-owned property in his/her possession or under
        his/her control, including, but not limited to, all keys or card keys to
        company buildings or property, all company-owned equipment, all company
        software, documents and papers (such as reports, blueprints, business
        plans and files), credit cards, cell phones, and all other Employer
        property. Employee shall return both originals and copies of such
        property and shall not use or transfer such property to others.

10.     In exchange for the severance pay and other benefits contained in this
        Agreement, which are in addition to the benefits Employee is otherwise
        entitled to receive, Employee and his/her successors and assigns forever
        release and discharge Employer, any of Employer's parent, subsidiary or
        related companies, any Employer-sponsored employee benefit plans in
        which Employee participates, and all of their respective officers,
        directors, trustees, agents, stockholders, employees, employees'
        spouses, and all of their successors and assigns (collectively
        "Releasees") from any and all employment-related claims, actions, causes
        of action, rights, or damages, including costs and attorneys' fees
        (collectively "Claims") which Employee may have on behalf of
        himself/herself, known, unknown, or later discovered which arose prior
        to the date Employee signs this Agreement.

        10.1.  This release includes but is not limited to, any Claims under any
               local, state, or federal laws prohibiting discrimination in
               employment, including without limitation the Civil Rights Acts,
               the Americans with Disabilities Act, the Age Discrimination in
               Employment Act or the Washington State Law Against
               Discrimination, or Claims under the Employee Retirement Income
               Security Act, any claims under

                                       2
<PAGE>

               the Family Medical Leave Act, or Claims alleging any legal
               restriction on Employer's right to terminate its employees, or
               personal injury Claims, including without limitation wrongful
               discharge, breach of contract, defamation, tortious interference
               with business expectancy, or infliction of emotional distress.

        10.2.  Employee represents that he/she has not filed any Claim against
               Employer or its Releasees, and that he/she will not do so at any
               time in the future concerning Claims released in this Agreement;
               provided, however, that this will not limit Employee from filing
               a Claim to enforce the terms of this Agreement.

11.     The parties pledge that they will take no action from this date forward
        that might interfere with the other's activities or damage the other's
        reputation. Prohibited actions would include, but not be limited to,
        private or public comments, statements, or writings critical,
        disparaging, or derogatory of the other party or the Releasees, or
        complaints filed against the other party or the Releasees with any
        regulatory agency.

12.     Employee understands and acknowledges the significance and consequences
        of this Agreement, admits that it is voluntary and that it has not been
        given as a result of any coercion, and expressly confirms that it is to
        be given full force and effect according to all of its terms, including
        those relating to unknown Claims. Employee was hereby advised of his/her
        right to seek the advice of an attorney prior to signing this Agreement.
        Employee acknowledges that he/she has signed this Agreement only after
        full reflection and analysis.

13.     Employee has a period of at least 7 days in which to consider this
        Agreement, but may sign it in less than 7 days at his/her option.

14.     Employer will pay the severance payment as promised in paragraph 4 to
        the Employee on the eighth (8th) day after Employee's execution of this
        Agreement.

15.     If any of the provisions of this Agreement are held to be invalid or
        unenforceable, the remaining provisions will nevertheless continue to be
        valid and enforceable.

16.     This Agreement and its attachments represents and contains the entire
        understanding between the parties in connection with its subject matter.
        All prior written or oral agreements or understandings are merged into
        and superseded by this Agreement. Employee acknowledges that in signing
        this Agreement, he/she has not relied upon any representation or
        statement not set forth in this Agreement made by Employer or any of its
        representatives.

17.     This Agreement is made and shall be construed and performed under the
        laws of the State of Washington.

                                       3
<PAGE>

PLEASE READ THIS AGREEMENT CAREFULLY. THIS SEVERANCE AND RELEASE AGREEMENT
INCLUDES A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS.

Dated:      4/15/02                            Dated:  4/17/02
      --------------------------                     ---------------------------

N2H2, INC.:                                    Elizabeth Hall:

By    /s/ Howard P. Welt                       /s/ Elizabeth Hall
      --------------------------               ---------------------------------

Its    CEO & President
      --------------------------

                                       4Exhibit 4.1

This Debenture has not been registered under the Securities Act of 1933, as
amended, and cannot be sold or transferred except in compliance with that Act.

                    SENIOR CONVERTIBLE SUBORDINATED DEBENTURE

$600,000

                                 April 23, 2002

      FOR VALUE RECEIVED, the undersigned, Ultralife Batteries, Inc., a Delaware
corporation ("Ultralife"), hereby promises to pay to Joseph C. Abeles
("Purchaser"), or order on December 31, 2002 (the "Maturity Date"), the
principal sum of Six-Hundred-Thousand Dollars ($600,000), and to pay simple
interest thereon, computed on the basis of a 360-day year of 12 30-day months,
from the date hereof at the rate of 10% per annum. Interest shall be calculated
monthly and shall be accrued through the Maturity Date.

      The principal hereof and interest hereon shall be payable at the office of
the undersigned, in such coin or currency of the United States of America as at
the time of payment shall be legal tender for the payment of public and private
debts.

      This Debenture is one of a duly authorized issue of debentures of
Ultralife Batteries, Inc. designated as its Senior Convertible Subordinated
Debentures due December 31, 2002 ("Debentures"), each such Debenture being
subject to the same terms and conditions as contained herein.

                              W I T N E S S E T H:
                              --------------------

                           I. Recording and Transfer.

      1.1 Ultralife will have the right at any time, or from time to time,
subsequent to the date hereof, to issue a new Debenture or Debentures to the
Purchaser or holder in printed form or in any other form in substitution for
this Debenture, provided that such substitute Debenture or Debentures shall
contain all the terms and conditions of this Debenture, and no other terms and
conditions. In the event of such reissuance of Debentures, the Purchaser or
holder will be obligated to return to Ultralife this Debenture, or any
subsequently issued Debentures, in exchange therefor.

      1.2 Ultralife will keep books at its principal office for the registration
or transfer of the Debentures, or Ultralife may designate any bank or trust
company or any registrar and transfer company as its Registrar and Transfer
Agent for such purpose. The person in whose name a Debenture shall be registered
on the books of Ultralife or its Transfer Agent shall be deemed and regarded as
the absolute owner thereof for all purposes, notwithstanding any notice or
knowledge to the contrary, and payment of the principal of, the interest on, or
the premium, if any, on the Debentures shall be made, and the conversion thereof
shall be effected, only by or upon the order of such registered owner. Any such
payment or conversion shall be valid and

<PAGE>

effectual to satisfy and discharge Ultralife of liability upon such Debenture to
the extent of such sum or sums so paid or the Common Stock of Ultralife issued
upon such conversion.

      1.3 Subject to the provisions hereof, the Debenture shall be treated as
negotiable, and the Purchaser may transfer or assign the Debenture, or any
portion thereof, subject to all of the provisions and obligations contained
herein. No transfer shall be valid unless made on the books of Ultralife or its
Transfer Agent. Such transfers may be effected on the books of Ultralife or its
Transfer Agent upon delivery of: (a) this Debenture, duly endorsed or
accompanied by a written instrument of transfer, with the signature of
endorsement guaranteed by a commercial bank or trust company; (b) a sum
sufficient to reimburse Ultralife for any documentary stock transfer tax or
other governmental charge imposed upon the transfer; and (c) a letter or other
document from the transferee, in form and content satisfactory to Ultralife,
stating that such transferee is acquiring the Debenture for his own account and
without a view to, or in connection with, any distribution thereof in violation
of the Securities Act of 1933, as amended (hereinafter referred to as the
"Act"), or applicable state law. Upon receipt of such documents, Ultralife shall
issue a new Debenture in the form of the original Debenture to the proper
parties as instructed by the transferor.

      1.4 Upon receipt of evidence satisfactory to Ultralife or its Transfer
Agent of the loss, theft, destruction or mutilation of this Debenture, together
with indemnification reasonably satisfactory to Ultralife and reimbursement for
all expenses incident thereto, Ultralife or its Transfer Agent shall issue and
deliver a new Debenture in lieu of any Debenture which may become lost, stolen,
destroyed or mutilated.

                               II. Subordination.

      The parties hereto agree that the payment of the principal of and the
interest on the Debenture is expressly subordinated to the payment of all Senior
Indebtedness, to the extent and subject to the conditions set forth in this
Article II. As used herein, the term "Senior Indebtedness" shall mean the
principal of, the interest on and the premium, if any, on all indebtedness of
Ultralife for money borrowed by it from any financial institution including
banks, savings institutions or insurance companies and all renewals, extensions
and refundings of any such indebtedness, whether such indebtedness shall have
been incurred prior to, on, or subsequent to the date hereof, unless by the
terms of the instrument creating or evidencing any such indebtedness it is
provided that such indebtedness is not to be considered Senior Indebtedness for
the purpose of the Debenture.

      2.1 No interest or principal shall be paid on the Debenture without the
consent of the holders of all outstanding Senior Indebtedness if, at the date
fixed herein for such interest or principal payment, Ultralife shall be in
default of payment of principal or interest upon such Senior Indebtedness. In
the event any payment of interest or principal hereunder shall be prohibited
pursuant to this Section 2. 1, such payment shall be deemed to be deferred until
the cure of all defaults in payment of principal or interest upon the Senior
Indebtedness, and the payments hereon so deferred shall immediately become due
and payable, without any interest thereon, upon the cure of such defaults.

      2.2 In the event of any dissolution, winding up, liquidation or
reorganization of

                                       2

<PAGE>

Ultralife, whether in bankruptcy, insolvency or receivership proceedings, or
upon an assignment for the benefit of creditors or in any other marshalling of
the assets and liabilities of Ultralife, the holders of all Senior Indebtedness
shall first be entitled to receive payment in full of such Senior Indebtedness
before the holders of the Debentures shall be entitled to receive any payment
upon the principal of, the interest on, or the premium, if any, on the
indebtedness evidenced by the Debentures. Upon any such dissolution, winding up,
liquidation or reorganization, any payment or distribution of assets of
Ultralife of any kind or character, whether in cash, property or securities, to
which the holders of the Debentures would be entitled, except for the provisions
of this Article II, shall be made by the liquidating trustee or agent or such
person making such payment or distribution, whether a trustee in bankruptcy, a
receiver or liquidating trustee or otherwise, directly to the holders of the
Senior Indebtedness or their representatives or to the trustee or trustees under
any indenture or indentures under which any instruments evidencing any such
Senior Indebtedness may have been issued, ratably according to the aggregate
amounts remaining unpaid on account of the Senior Indebtedness held or
represented by each, to the extent necessary to pay in full all such Senior
Indebtedness remaining unpaid, after giving effect to all concurrent payment or
distribution with respect to such Senior Indebtedness.

      2.3 In the event that, notwithstanding the provisions of Section 2.2 of
this Article II, upon any such dissolution, winding up, liquidation or
reorganization, any payment or distribution of assets of Ultralife of any kind
or character, whether in cash, property or securities, shall be received by the
holders of the Debentures before all Senior Indebtedness is paid in full, such
payment or distribution shall be paid over to the holders of such Senior
Indebtedness or their representatives or to the trustee or trustees under any
indenture or indentures referred to in said Section 2.2, ratably as aforesaid,
for application to the payment of all Senior Indebtedness remaining unpaid until
all such Senior Indebtedness shall have been paid in full, after giving effect
to any concurrent payment or distribution with respect to such Senior
Indebtedness.

      2.4 Subject to the payment in full of all Senior Indebtedness, the holders
of the Debentures, to the extent permitted by law, shall be subrogated to the
rights of each holder of Senior Indebtedness (to the extent of the payments or
distributions made to such holder pursuant to the provisions of Sections 2.2 and
2.3 of this Article II) to receive payments or distributions of assets of
Ultralife applicable to the Senior Indebtedness until the principal of, the
interest on, and the premium, if any, on this Debenture shall be paid in full,
and each holder of Senior Indebtedness by accepting such payments or
distributions shall be deemed to have agreed to said subrogation. No payments or
distributions to the Senior Indebtedness pursuant to the provisions of Sections
2.2 and 2.3 shall, as between Ultralife, its creditors, other than the holders
of the Senior Indebtedness, and the holders of the Debentures, be deemed to be a
payment by Ultralife to or on account of the Debentures, the provisions of this
Article II being, and being intended, solely for the purpose of defining the
relative rights of the holders of the Debentures, on the one hand, and the
holders of the Senior Indebtedness, on the other hand; and nothing contained in
this Article II or elsewhere in this Debenture is intended to or shall impair,
as between Ultralife, the holders of the Debentures and the other creditors of
Ultralife, other than the holders of Senior Indebtedness, the obligation of
Ultralife, which is unconditional and absolute, to pay to the holders of the
Debentures as and when the same shall become due and payable in accordance with
the terms herein, or to affect the relative rights of the holders of the
Debentures and the other creditors of Ultralife, other than the holders of
Senior Indebtedness, or to prevent the holders of the Debentures from exercising
all of the remedies otherwise permitted by applicable law upon default as
provided for herein, subject to the rights, if any, under this Article II of the

                                       3

<PAGE>

holders of the Senior Indebtedness in respect of any cash, property or
securities of Ultralife received upon the exercise of any such remedy.

      2.5 In the event that this Debenture shall be declared due and payable
before the Maturity Date because of the occurrence of a default hereunder,
Ultralife will give prompt notice in writing of such happening to the holders of
the Senior Indebtedness, and any and all Senior Indebtedness shall forthwith
become immediately due and payable upon demand by the respective holders thereof
regardless of the expressed maturity dates thereof.

                                III. Conversion.

      The Purchaser agrees that at any time prior to the Maturity Date hereof,
if Ultralife obtains the approval of the holders of a majority of the issued and
outstanding shares of its $.10 per value Common Stock ("Common Stock") of the
conversion of this Debenture, the principal amount of the Debenture shall
automatically and mandatorily convert into Common Stock. The conversion price
shall be Three Dollars and no Cents ($3.00) per share (hereinafter referred to
as the "Conversion Price") subject to the following terms and conditions:

      3.1 Interest shall cease to accrue on the principal amount of the
Debenture converted pursuant to the provisions of this Article III, immediately
upon, and as of, the conversion thereof, and any and all accrued interest shall
be forfeited by the Purchaser. As promptly as shall be practicable after the
surrender of the Debenture for conversion in whole or in part, Ultralife will
issue and deliver to the Purchaser or holder, the number of whole shares of
Common Stock into which the Debenture shall be so converted. Such conversion
shall for all purposes be deemed to have been effected at the close of business
on the day of obtaining stockholder approval of the conversion of this
Debenture.

      3.2 In connection with the conversion, if there is not an effective
registration statement with respect to the shares of Common Stock issuable on
conversion, Ultralife reserves the right to imprint restrictive legends on the
certificates representing the shares of Common Stock into which the Debenture
shall be converted and to place stop transfer orders against the same. Nothing
contained herein shall be construed as requiring counsel for Ultralife to
subsequently issue any opinion letter that registration is not required, and
such counsel may refuse to issue such an opinion letter on any reasonable
grounds or may require opinion letters from counsel for the proposed transferor,
affidavits from the proposed transferor or transferee, letters from the
Securities and Exchange Commission or any other documents which said counsel may
deem to be necessary or desirable and proper as a condition precedent to issuing
such an opinion letter.

      3.3 In the event that at any time the Common Stock of Ultralife shall be
exchanged for, or changed into, a different kind and/or a number of shares of
stock of Ultralife or of another corporation by reason of a merger,
consolidation, sale of assets, recapitalization, reclassification, stock
dividend, stock split-up or combination of shares or otherwise, then, until any
further adjustment is required, there shall be issuable upon the conversion of
this Debenture, in lieu of each share of Common Stock of Ultralife or of any
other stock theretofore issued pursuant to the provisions of this Article III,
the kind and/or number of shares of stock for which each share of Common Stock
of Ultralife or such other stock shall be so exchanged, or into which each share
of Common Stock of Ultralife or such other stock shall be so changed and the
Conversion Price

                                       4

<PAGE>

of Three Dollars and no cents ($3.00) per share of Common Stock shall be
automatically adjusted to a new Conversion Price as nearly equivalent as
practicable to the adjustment in shares of stock, if by reason of such merger,
consolidation, recapitalization, reclassification or otherwise the number of
issued and outstanding shares of Common Stock of Ultralife shall have been
exchanged for or changed into such new shares on other than a one-to-one basis.
If such event requires an adjustment in the Conversion Price, Ultralife shall
mail notice of the nature of such event and the new Conversion Price to the
Purchaser at the Purchaser's registered address within ten (10) days after the
occurrence of such event.

      3.4 No adjustment in the Conversion Price shall be made for cash dividends
on the shares of Common Stock of Ultralife or any other stock issued upon any
conversion of the Debenture. No fractional shares or scrip representing
fractional shares will be issued upon the conversion of the Debentures. In lieu
of the issuance of any fractional share otherwise called for upon such
conversion, Ultralife will pay to the Purchaser or holder an amount in cash
equal to the value of such fractional share, based upon the Conversion Price.

      3.5 Ultralife shall at all times, prior to the maturity date of the
Debenture, reserve and keep available out of its authorized but unissued Common
Stock, solely for the purposes of issuance upon conversion of Debentures as
herein provided an appropriate number of shares of Common Stock as shall be
issuable upon the conversion of the Debenture. Such shares of Common Stock when
issued upon conversion shall be duly and validly issued and fully-paid and
non-assessable; however, unless such shares have been registered under the Act,
such shares of Common Stock will be restricted and subject to restrictions on
resale.

                IV. Representations and Warranties of Ultralife.

      Ultralife represents and warrants to the Purchaser as follows:

      4.1 Ultralife is duly incorporated, validly existing and in good standing
under the laws of the State of Delaware, and Ultralife is qualified to transact
business and is in good standing in all states in which it owns property, and
has power and authority to own its property and to carry on its business as now
being conducted.

      4.2 All necessary action on the part of Ultralife relating to the
authorization of the execution and delivery of this Debenture and the
performance of its other obligations hereunder has been taken, and all of the
same shall be valid and enforceable in accordance with their respective terms,
except as may be limited by bankruptcy, insolvency or other laws of general
application relating to or affecting the enforcement of creditors' rights. Such
action will not violate any provision of law, or of Ultralife's Certificate of
Incorporation or By-Laws, and will not violate or create a default under any
agreement to which Ultralife is a party, or by which any of its properties is
bound, or any order, writ, injunction or decree of any Court or governmental.
instrumentality, and will not result in the creation or imposition of any lien,
charge or encumbrance upon any of the properties of Ultralife.

                                  V. Default.

      In the event that there shall be any Event of Default hereunder and such
Event of Default shall remain uncorrected or unremedied for a period of more
than thirty (30) days after Ultralife

                                       5

<PAGE>

shall have received notice of such Event of Default from the Purchaser or other
holders of Debentures, then such portion of the Debenture with respect to which
the Event of Default occurred may, at the option of the Purchaser or the holders
thereof, become immediately due and payable without further notice by the
Purchaser or holders thereof.

"Event of Default" as used in this Article V shall mean and refer to any of the
following: (i) the failure of Ultralife to pay any installment of interest or
principal on any of the Debentures when and as the same shall become due and
payable, whether at maturity, by call for redemption, by declaration or
otherwise; (ii) the failure of Ultralife to cure a default declared by the
holder of Senior Indebtedness within the applicable period of time to cure such
default; (iii) the failure of Ultralife to observe and perform all of the
covenants and agreements on the part of Ultralife contained herein; (iv) failure
of any representation or warranty made by Ultralife herein to be truthful,
accurate or correct; (v) the adjudication of Ultralife as a bankrupt by a court
of competent jurisdiction or the entry by a court of competent jurisdiction of
an order approving a petition seeking reorganization of Ultralife under the
federal bankruptcy laws or any other applicable law or statute of the United
States of America or any state thereof or any other jurisdiction; (vi) the
appointment by a court of competent jurisdiction of a trustee or receiver or
receivers of Ultralife of all or any substantial part of its property upon the
application of any creditor in any insolvency or bankruptcy proceeding or other
creditor's suit, unless such appointment or decree or order shall be stayed upon
appeal or otherwise; (vii) the filing by Ultralife of a petition in voluntary
bankruptcy or the making by Ultralife of an assignment for the benefit of its
creditors or the consenting by Ultralife to the appointment of a receiver or
receivers of all or any substantial portion of the property of Ultralife; (viii)
the filing by Ultralife of a petition or answer seeking reorganization under the
federal bankruptcy laws or any other applicable law or statute of the United
States of America or any state thereof or any jurisdiction, or the filing by
Ultralife of a petition to take advantage of any debtor's act.

      5.1 Upon the occurrence of an Event of a Default, each holder of any of
the Debentures shall at all times have the right to institute any suit, action
or proceeding, in equity or at law, for the enforcement of his rights as
provided for herein, or in aid of the exercise of any right or power granted
herein.

      5.2 The Debentures shall be the obligation of Ultralife solely and there
shall be no recourse had for the payment thereof or interest thereon against any
stockholder, officer or director of Ultralife, either directly or through
Ultralife, by reason of any matter prior to the delivery of the Debentures, or
against any present or future officer or director of Ultralife, all such
liability being expressly released by the Purchaser and by any subsequent
holders hereof by the acceptance hereof and as part of the consideration for the
issue hereof.

                               VI. Miscellaneous.

      6.1 All notices and other communications required to be given hereunder
shall be in writing, by certified mail, postage prepaid, return receipt
requested, addressed to Ultralife at its principal office or to the holder of
the Debenture at his registered address as reflected on the books and records of
Ultralife or its Transfer Agent.

                                       6

<PAGE>

      6.2 This Debenture represents the entire agreement between the parties
hereto and may not be modified or rescinded except by mutual agreement of the
parties hereto, except in accordance with the terms herein.

      6.3 No waiver of any breach of this Debenture shall be deemed or construed
as a waiver of any subsequent breach thereof.

      6.4 This Debenture may not be assigned by the Purchaser except in
accordance with the provisions hereof. This Debenture shall inure to the benefit
of, and be binding upon, the successors and assigns of Ultralife.

      6.5 The headings of the Articles of this Debenture are inserted for
convenience only and do not constitute a part hereof.

      6.6 Throughout this Debenture, the masculine gender shall be deemed to
include the feminine and neuter, and the singular the plural, and vice versa.

      IN WITNESS WHEREOF, Ultralife has executed this Debenture on April 23,
2002.

                                           ULTRALIFE BATTERIES, INC.

                                           By: /s/ John D. Kavazanjian
                                               ------------------------------
                                               John D. Kavazanjian, President

ATTEST:

/s/ Peter F. Comerford
-----------------------------
Peter F. Comerford, Secretary

                                       7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00039-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00039-of-00352.parquet"}]]